CLINICAL_TRIALS
trial_result
· 2011-05-19
Clinical Trial Update: Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris [Phase 4]
Summary
Phase 4 trial comparing the efficacy and safety of norgestimate/ethinyl estradiol versus cyproterone acetate/ethinyl estradiol for acne vulgaris; study complete…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED